Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2023-12-06 Share Issue/Capital Cha…
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
NASDAQ Confirms First Trading Date of Consolidated ADS 2 pages 101.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an ASX market announcement regarding the confirmation of the first trading date of consolidated American Depositary Shares (ADS) for Genetic Technologies Limited. It details the timetable for the share consolidation process, including key dates for trading and record dates. The document is an announcement about a capital structure change (share consolidation) rather than a full financial report or detailed presentation. It does not contain financial statements or detailed financial analysis, nor is it a report publication or certification. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as share consolidations.
2023-12-06 English
Update - Consolidation/Split - GTG 5 pages 28.3KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Consolidation/Split' and details a security consolidation (reverse stock split) for Genetic Technologies Limited. It includes specifics such as the consolidation ratio, affected securities, timetable for the consolidation, approvals obtained, and changes in the number of securities before and after the consolidation. There is no financial performance data, earnings information, or management discussion. The document is an official announcement regarding a capital structure change (reverse split). This fits the category of Share Issue/Capital Change (SHA), which covers announcements about new share issues, stock splits, or other capital changes.
2023-12-05 English
Updated Share Consolidation Timetable 2 pages 100.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX Market Announcement from Genetic Technologies Limited regarding an updated timetable for a shareholder-approved 100:1 share consolidation. It details key dates for trading and record dates related to the share consolidation event. There is no financial data, earnings information, or detailed report content. The document is an announcement about a capital structure change (share consolidation). According to the filing definitions, announcements about share consolidations or capital changes fall under the category 'Share Issue/Capital Change' (Code: SHA). The document length is 4723 characters, which is sufficient for a detailed announcement but does not constitute a full financial report. Therefore, the correct classification is SHA with high confidence.
2023-12-05 English
Notification of cessation of securities - GTG 4 pages 23.8KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification about the cessation of securities, specifically options that have expired without exercise or conversion. It provides details about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement of a change in the company's issued capital related to securities ceasing to exist. It is not a financial report, audit, or management discussion, nor is it a detailed capital raising or financing update. It fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as cessation of securities.
2023-12-03 English
Update - Consolidation/Split - GTG 5 pages 28.3KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Consolidation/Split' and details a security consolidation (reverse stock split) for Genetic Technologies Limited. It includes specifics such as the consolidation ratio, affected securities, timetable for the consolidation, approvals obtained, and changes in the number of securities pre- and post-consolidation. There is no financial performance data, earnings information, or management discussion. The document is an official announcement about a capital structure change (reverse split) rather than a report or presentation. This fits the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues, stock splits, or other capital changes.
2023-11-30 English
Change to Share Consolidation Timetable 2 pages 100.2KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX market announcement from Genetic Technologies Limited regarding a change to the timetable for a shareholder-approved 100:1 share consolidation. It provides detailed dates and events related to the share consolidation process, including trading dates and record dates. There is no financial data, earnings information, or detailed report content. The document is an announcement about a capital structure change (share consolidation) rather than a full report or financial statement. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is 4631 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is SHA with high confidence.
2023-11-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.